HCV Replicon Systems: Workhorses of Drug Discovery and Resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HCV Replicon Systems: Workhorses of Drug Discovery and Resistance

Published:2020-06-30 Issue: Volume:10 Page:
ISSN:2235-2988
Container-title:Frontiers in Cellular and Infection Microbiology
language:
Short-container-title:Front. Cell. Infect. Microbiol.

Author:

Khan Shaheen,Soni Shalini,Veerapu Naga Suresh

Funder

Department of Biotechnology, Ministry of Science and Technology

Publisher

Frontiers Media SA

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference139 articles.

1. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N. Engl. J. Med,2014

2. Novel synthesis and phenotypic analysis of mutant clouds for hepatitis E virus genotype 1;Agarwal;J. Virol,2018

3. Mechanisms of hepatitis C viral resistance to direct acting antivirals;Ahmed;Viruses,2015

4. Epidemiology and treatment of hepatitis C genotypes 5 and 6;Al Naamani;Can. J. Gastroenterol,2013

5. Overview of HCV life cycle with a special focus on current and possible future antiviral targets;Alazard-Dany;Viruses,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Epigenetic Controller Lysine-Specific Demethylase 1 (LSD1) Regulates the Outcome of Hepatitis C Viral Infection;Cells;2023-11-03

2. Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis;Frontiers in Cellular and Infection Microbiology;2023-10-24

3. Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced Cytopathology;Viruses;2023-05-30

4. Generation of a SARS-CoV-2 reverse genetics system and novel human lung cell lines that exhibit high virus-induced cytopathology;2023-03-09

5. Reverse genetic systems of SARS-CoV-2 for antiviral research;Antiviral Research;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3